BIOCON Biocon Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals
Sector: HealthcareLive setups screens BIOCON is on right now — tap to see every stock matching
Smart Money Verdict synthesis of derivatives, deals, and promoter files
Analysis what the data is telling us about BIOCON
In the last completed session, Biocon Ltd. closed -0.08% with futures open interest moving -1.3%. That combination — price falling while OI shrinks — is classified as Long Unwinding. Existing longs are exiting rather than new shorts being added; the move down lacks the conviction of fresh selling. The option PCR of 0.85 is balanced — no clear directional preference from option writers. Max-pain strike at ₹430 sits 2.3% below the current price, a mild magnet near expiry.
On the institutional side, MFs have been adding to Biocon Ltd. — the most recent notable was ICICI PRUDENTIAL MUTUAL FUND on the buy side at ₹738 Cr.
Putting it together, the smart-money picture for Biocon Ltd. points to a softer setup at the next open. The next scheduled earnings report is on 2026-08-06, with the consensus EPS estimate at ₹1.005. Earnings days routinely override positioning signals — keep an eye on the calendar.
F&O Positioning EOD derivatives setup
Quote Details key metrics & weights
Technical Snapshot from 400 sessions of price history
Key Fundamentals headline ratios · Healthcare
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
Institutional Deals last 30 sessions (bulk & block)
| Date | Side | Price | Value (Cr) | Counterparty |
|---|---|---|---|---|
| 2026-07-14 | SELL | ₹ 400.00 | 1,839.34 | MYLAN INC. |
| 2026-07-14 | SELL | ₹ 400.00 | 1,839.34 | MYLAN INC. |
| 2026-07-14 | BUY | ₹ 400.00 | 737.50 | ICICI PRUDENTIAL MUTUAL FUND MF |
| 2026-07-14 | BUY | ₹ 400.00 | 737.50 | ICICI PRUDENTIAL MUTUAL FUND MF |
| 2026-07-14 | BUY | ₹ 400.00 | 233.16 | HDFC MUTUAL FUND MF |
| 2026-07-14 | BUY | ₹ 400.00 | 233.16 | KOTAK MAHINDRA MUTUAL FUND MF |
| 2026-07-14 | BUY | ₹ 400.00 | 75.00 | SBI MUTUAL FUND MF |
| 2026-07-14 | BUY | ₹ 400.00 | 50.00 | ADITYA BIRLA SUNLIFE MUTUAL FUND MF |
| 2026-07-14 | BUY | ₹ 400.00 | 50.00 | ICICI PRUDENTIAL LIFE INSURANCECOMPANY LTD. Insurance |
| 2026-07-14 | BUY | ₹ 400.00 | 37.50 | FRANKLIN TEMPLETON MUTUAL FUND FII |
Broker Calls as reported · last 120 days
| Date | Brokerage | Call | Target | Source |
|---|---|---|---|---|
| 2026-07-17 | Bernstein | Underperform | — | NDTV Profit |
| 2026-07-16 | Bernstein | Underperform | — | NDTV Profit |
| 2026-07-15 | Bernstein | Underperform | — | NDTV Profit |
Insider & Promoter Filings last 60 days
Option Chain Ladder nearest expiry 2026-07-28 · spot 436 · EOD 2026-07-20
| Call OI (writers) | Strike | Put OI (writers) |
|---|---|---|
|
IV 59%
Δ 0.84
θ -0.7
ν 0
|
405 | |
|
IV 35%
Δ 0.91
θ -0.3
ν 0
|
410 | |
|
IV 32%
Δ 0.88
θ -0.3
ν 0
|
415 | |
|
IV 31%
Δ 0.83
θ -0.4
ν 0
|
420 |
IV 30%
Δ -0.16
θ -0.3
ν 0
|
|
IV 32%
Δ 0.74
θ -0.5
ν 0
|
425 |
IV 29%
Δ -0.24
θ -0.4
ν 0
|
|
IV 30%
Δ 0.66
θ -0.5
ν 0
|
430 MP |
IV 29%
Δ -0.33
θ -0.4
ν 0
|
|
IV 30%
Δ 0.55
θ -0.6
ν 0
|
435 |
IV 29%
Δ -0.45
θ -0.5
ν 0
|
|
IV 31%
Δ 0.45
θ -0.6
ν 0
|
440 |
IV 29%
Δ -0.56
θ -0.5
ν 0
|
|
IV 31%
Δ 0.35
θ -0.5
ν 0
|
445 |
IV 29%
Δ -0.66
θ -0.4
ν 0
|
|
IV 32%
Δ 0.26
θ -0.5
ν 0
|
450 R |
IV 30%
Δ -0.75
θ -0.3
ν 0
|
|
IV 33%
Δ 0.19
θ -0.4
ν 0
|
455 |
IV 30%
Δ -0.83
θ -0.3
ν 0
|
|
IV 34%
Δ 0.14
θ -0.3
ν 0
|
460 |
IV 27%
Δ -0.91
θ -0.1
ν 0
|
| 465 |
IV 33%
Δ -0.91
θ -0.2
ν 0
|
Chain Interpretation
Strategy Builder multi-leg payoff for BIOCON options · 2026-07-28 expiry
Legs
Payoff at expiry
Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others
BIOCON — frequently asked questions
What is the Biocon Ltd. share price today?
BIOCON is trading at ₹440.30 (+0.87% vs previous close), per the latest update on this page.
What is the P/E ratio of Biocon Ltd.?
BIOCON (Biocon Ltd.) has a trailing twelve-month P/E ratio of 155.0.
What is the market cap of Biocon Ltd.?
BIOCON has a market capitalisation of approximately ₹71,694 crore.
What is the ROE of Biocon Ltd.?
BIOCON has a return on equity (ROE) of about 1.1%.
Is BIOCON near its 52-week high?
BIOCON is trading -2.4% from its 52-week high of ₹447.15 as of 2026-07-20.
What is the RSI of BIOCON?
The 14-day RSI of BIOCON is 59.8, which is considered neutral.
Is BIOCON above its 200-day moving average?
BIOCON is trading above its 200-DMA of ₹387.61 (+12.6% away).
What is the F&O buildup in BIOCON?
The latest end-of-day derivatives data classifies BIOCON as Long Unwinding (bias: bearish), based on the day's combined price and open-interest change.
What is the max pain and PCR for BIOCON options?
BIOCON's option-chain max pain strike is ₹430 and its put-call ratio (OI) is 0.85, from the latest end-of-day option chain.
Are FIIs or big investors buying BIOCON?
Strota tracks every bulk and block deal in BIOCON with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.
What is the latest broker call on BIOCON?
The most recent analyst call reported in the press is Bernstein: Underperform (2026-07-17). The Broker Calls section on this page lists reported calls from the last 120 days with links to the original reports.